Idexx Laboratories Stock Analysis

IDXX Stock  USD 444.53  15.23  3.31%   
IDEXX Laboratories is fairly valued with Real Value of 452.69 and Target Price of 478.62. The main objective of IDEXX Laboratories stock analysis is to determine its intrinsic value, which is an estimate of what IDEXX Laboratories is worth, separate from its market price. There are two main types of IDEXX Laboratories' stock analysis: fundamental analysis and technical analysis.
The IDEXX Laboratories stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. IDEXX Laboratories is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. IDEXX Stock trading window is adjusted to America/New York timezone.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.

IDEXX Stock Analysis Notes

About 92.0% of the company shares are owned by institutional investors. The company recorded earning per share (EPS) of 10.67. IDEXX Laboratories had not issued any dividends in recent years. The entity had 2:1 split on the 16th of June 2015. IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine. Idexx Laboratories operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 10000 people. To learn more about IDEXX Laboratories call Jonathan Mazelsky at 207 556 0300 or check out https://www.idexx.com.

IDEXX Laboratories Quarterly Total Revenue

954.29 Million

IDEXX Laboratories Investment Alerts

IDEXX Laboratories is unlikely to experience financial distress in the next 2 years
IDEXX Laboratories currently holds 1.07 B in liabilities with Debt to Equity (D/E) ratio of 3.28, implying the company greatly relies on financing operations through barrowing. IDEXX Laboratories has a current ratio of 0.87, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about IDEXX Laboratories' use of debt, we should always consider it together with its cash and equity.
Over 92.0% of IDEXX Laboratories shares are owned by institutional investors
Latest headline from finance.yahoo.com: IDEXX Laboratories Fell Due to Weakening of Clinical Visits by Patients

IDEXX Laboratories Upcoming and Recent Events

Earnings reports are used by IDEXX Laboratories to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
5th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
5th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

IDEXX Largest EPS Surprises

Earnings surprises can significantly impact IDEXX Laboratories' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2003-10-20
2003-09-300.10.110.0110 
2003-04-21
2003-03-310.080.090.0112 
2002-07-15
2002-06-300.080.090.0112 
View All Earnings Estimates

IDEXX Laboratories Environmental, Social, and Governance (ESG) Scores

IDEXX Laboratories' ESG score is a quantitative measure that evaluates IDEXX Laboratories' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of IDEXX Laboratories' operations that may have significant financial implications and affect IDEXX Laboratories' stock price as well as guide investors towards more socially responsible investments.

IDEXX Laboratories Thematic Classifications

In addition to having IDEXX Laboratories stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Healthcare Idea
Healthcare
USA Equities from Healthcare industry as classified by Fama & French

IDEXX Stock Institutional Investors

Shares
Blair William & Co2024-09-30
1.2 M
Brown Advisory Holdings Inc2024-09-30
1.1 M
Amvescap Plc.2024-09-30
1.1 M
Fundsmith Investment Services Ltd.2024-09-30
865 K
Legal & General Group Plc2024-09-30
774.7 K
Northern Trust Corp2024-09-30
769.5 K
Goldman Sachs Group Inc2024-09-30
768.6 K
Ubs Asset Mgmt Americas Inc2024-09-30
751.9 K
Principal Financial Group Inc2024-12-31
711.2 K
Vanguard Group Inc2024-09-30
9.7 M
Blackrock Inc2024-09-30
9.4 M
Note, although IDEXX Laboratories' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

IDEXX Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 36.4 B.

IDEXX Profitablity

The company has Profit Margin (PM) of 0.23 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.27 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.27.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.27  0.14 
Return On Capital Employed 0.43  0.26 
Return On Assets 0.23  0.24 
Return On Equity 0.65  0.69 

Management Efficiency

IDEXX Laboratories has return on total asset (ROA) of 0.2152 % which means that it generated a profit of $0.2152 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.5766 %, meaning that it created $0.5766 on every $100 dollars invested by stockholders. IDEXX Laboratories' management efficiency ratios could be used to measure how well IDEXX Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. At this time, IDEXX Laboratories' Return On Assets are fairly stable compared to the past year. Return On Equity is likely to rise to 0.69 in 2025, whereas Return On Tangible Assets are likely to drop 0.14 in 2025. At this time, IDEXX Laboratories' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 2.1 B in 2025, whereas Intangible Assets are likely to drop slightly above 74.5 M in 2025.
Last ReportedProjected for Next Year
Book Value Per Share 16.08  16.89 
Tangible Book Value Per Share 11.20  11.76 
Enterprise Value Over EBITDA 34.53  36.26 
Price Book Value Ratio 35.72  37.50 
Price Fair Value 35.72  37.50 
Enterprise Value Multiple 34.53  36.26 
Enterprise Value7.2 B7.6 B
The management strategies employed by IDEXX Laboratories' are designed to enhance shareholder value and ensure long-term growth. We assess the effectiveness of these strategies in our stock analysis.
Operating Margin
0.2742
Profit Margin
0.2278
Beta
1.366
Return On Assets
0.2152
Return On Equity
0.5766

Technical Drivers

As of the 16th of February 2025, IDEXX Laboratories retains the Risk Adjusted Performance of 0.0269, semi deviation of 1.56, and Market Risk Adjusted Performance of 0.1263. IDEXX Laboratories technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

IDEXX Laboratories Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. IDEXX Laboratories middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for IDEXX Laboratories. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

IDEXX Laboratories Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific IDEXX Laboratories insiders, such as employees or executives, is commonly permitted as long as it does not rely on IDEXX Laboratories' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases IDEXX Laboratories insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

IDEXX Laboratories Outstanding Bonds

IDEXX Laboratories issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. IDEXX Laboratories uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most IDEXX bonds can be classified according to their maturity, which is the date when IDEXX Laboratories has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

IDEXX Laboratories Predictive Daily Indicators

IDEXX Laboratories intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of IDEXX Laboratories stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

IDEXX Laboratories Corporate Filings

8K
14th of February 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
12th of February 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
11th of February 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
10th of February 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
3rd of February 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F5
21st of January 2025
The annual filing required by the Securities and Exchange Commission (SEC) from company insiders or beneficial owners
ViewVerify
8K
12th of December 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
9th of December 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

IDEXX Laboratories Forecast Models

IDEXX Laboratories' time-series forecasting models are one of many IDEXX Laboratories' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary IDEXX Laboratories' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About IDEXX Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how IDEXX Laboratories prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling IDEXX shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as IDEXX Laboratories. By using and applying IDEXX Stock analysis, traders can create a robust methodology for identifying IDEXX entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.28  0.30 
Operating Profit Margin 0.29  0.30 
Net Profit Margin 0.23  0.24 
Gross Profit Margin 0.61  0.61 

Current IDEXX Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. IDEXX analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. IDEXX analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
478.62Buy14Odds
IDEXX Laboratories current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most IDEXX analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand IDEXX stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of IDEXX Laboratories, talking to its executives and customers, or listening to IDEXX conference calls.
IDEXX Analyst Advice Details

IDEXX Stock Analysis Indicators

IDEXX Laboratories stock analysis indicators help investors evaluate how IDEXX Laboratories stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading IDEXX Laboratories shares will generate the highest return on investment. By understating and applying IDEXX Laboratories stock analysis, traders can identify IDEXX Laboratories position entry and exit signals to maximize returns.
Begin Period Cash Flow453.9 M
50 Day M A431.9674
Common Stock Shares Outstanding83.1 M
Other Operating Expenses2.8 B
Quarterly Earnings Growth Y O Y0.134
Forward Price Earnings37.8788

Additional Tools for IDEXX Stock Analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.